A phase I trial of nelfinavir (Viracept) in adults with solid tumors.

Trial Profile

A phase I trial of nelfinavir (Viracept) in adults with solid tumors.

Completed
Phase of Trial: Phase I

Latest Information Update: 19 May 2017

At a glance

  • Drugs Nelfinavir (Primary) ; Midazolam
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 30 May 2012 Additional lead trial investigator (Giaccone G) identified as reported by ClinicalTrials.gov. (NCT01445106)
    • 30 May 2012 Additional lead trial investigator (Giaccone G) identified as reported by ClinicalTrials.gov. (NCT01445106)
    • 23 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top